10,11-methylenedioxycamptothecin

Known as: MDCPT cpd 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2014
0119912014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
This study designs an alternative transdermal delivery system for 10,11-methylenedioxycamptothecin(MD-CPT) to inhibit keloid… (More)
Is this relevant?
2005
2005
In an effort to further extend the number of targets for development of antiretroviral agents, we have used an in vitro integrase… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2004
2004
Camptothecin (CPT) analogs that form more stable ternary complexes with DNA and topoisomerase I (termed cleavable complexes) show… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2001
2001
UCN-01 is a hydroxylated derivative of staurosporine and a potent protein kinase C (PKC) inhibitor. Interest in the potential… (More)
Is this relevant?
1996
1996
20(S)-Camptothecin (CPT), a topoisomerase I inhibitor specifically toxic toward S-phase cells, was tested topically for its… (More)
Is this relevant?
1995
1995
Camptothecins belong to a group of anticancer agents with a specific mechanism of action: stabilization and trapping of… (More)
Is this relevant?
1993
1993
The cytotoxic alkaloid camptothecin (CPT) and several of its analogues, including the clinically relevant topotecan (TPT… (More)
Is this relevant?
1991
1991
Previous studies in rapidly proliferating rodent cells have suggested that the lethal effect of the DNA topoisomerase I inhibitor… (More)
Is this relevant?